4.5 Article

Cost-effectiveness of Human Papillomavirus Self-collection Intervention on Cervical Cancer Screening Uptake among Underscreened US Persons with a Cervix

期刊

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
卷 32, 期 8, 页码 1097-1106

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-22-1267

关键词

-

向作者/读者索取更多资源

This study evaluated the cost-effectiveness of mailing HPV self-collection kits to underscreened individuals. The results showed that mailing HPV self-collection kits was more cost-effective and increased screening uptake compared to scheduling assistance and usual care.
Background: We evaluate the cost-effectiveness of human papillomavirus (HPV) self-collection (followed by scheduling assistance for those who were HPV thorn or inconclusive) compared with scheduling assistance only and usual care among underscreened persons with a cervix (PWAC).Methods: A decision tree analysis was used to estimate the incremental cost-effectiveness ratios (ICER), or the cost per additional PWAC screened, from the Medicaid/state and clinic perspectives. A hypothetical cohort represented 90,807 lowincome, underscreened individuals. Costs and health outcomes were derived from the MyBodyMyTest-3 randomized trial except the usual care health outcomes were derived from literature. We performed probabilistic sensitivity analyses (PSA) to evaluate model uncertainty. Results: Screening uptake was highest in the self-collection alternative (n = 65,721), followed by the scheduling assistance alternative (n = 34,003) and usual care (n = 18,161). The self collection alternative costs less and was more effective than the scheduling assistance alternative from the Medicaid/state perspective. Comparing the self-collection alternative with usual care, the ICERs were $284 per additional PWAC screened from the Medicaid/state perspective and $298 per additional PWAC screened from the clinic perspective. PSAs demonstrated that the self collection alternative was cost-effective compared with usual care at a willingness-to-pay threshold of $300 per additional PWAC screened in 66% of simulations from the Medicaid/state perspective and 58% of simulations from the clinic perspective.Conclusions: Compared with usual care and scheduling assistance, mailing HPV self-collection kits to underscreened individuals appears to be cost-effective in increasing screening uptake.Impact: This is the first analysis to demonstrate the costeffectiveness of mailed self-collection in the United States.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据